Bioinformatics Market Analysis, Size, Growth, Share & Forecast to 2020 | Grand View Research Inc.
“Bioinformatics Market Size To Reach $13.47 Billion By 2020”
The global bioinformatics market is expected to reach USD 13.47 billion by 2020 growing at an estimated CAGR of 21.2% from 2014 to 2020, according to a new report by Grand View Research, Inc. Growing clinical development of biopharmaceutical and increasing need for three dimensional drug designing technology are expected to drive the market growth over the next five years. Further development of bioinformatics tools, platforms and analysis platforms coupled with the introduction of novel technologies are expected to be high impact rendering factors for the growth of this market. Increasing demand for faster development of novel API and biopharmaceuticals is also expected to enhance the growth of this industry. Growth in the number of research and development studies in various ‘-omics’ related segments and need for integration of the large amounts of biological data generated from these studies is also expected to encourage industry players to develop faster, more efficient and versatile bioinformatics software cum platforms for commercialization. Bio-content processing accounted for over 47% of the revenue share in 2013. The presence of increasing market demand for genetic databases management, and need for related sequence, structural and phylogenic analysis tools and software is the primary factor accounting for this large share. For Latest research study :@ https://www.grandviewresearch.com/industry-analysis/bioinformatics-industry
Follow Us:
Moreover, the sequence and structural analysis platform segment is expected to grow at the fastest CAGR of over 20% over the forecast period owing to the development of next generation sequencing and expected reduction in cost of whole genome exome sequencing. These factors are expected to have a significantly positive impact on the overall growth of this market in the next five years. Chemo-informatics and genomics accounted for over 50% of revenue share in 2013. Growing demand for novel biomarkers for R&D of biosimilar drugs and biopharmaceuticals is expected to significantly enhance the market penetration over the forecast period. Proteomic applications are expected to attract a considerable amount of R&D investment in the near future and witness a lucrative growth over the forecast period. Developments in three dimensional drug development technologies are further expected to boost the growth of this segment. Key players in this industry include IBM Life Sciences, BIOVIA, Life Technologies Corporation, Agilent technologies, 3rd Millennium Inc., Celera Corporation, Affymetrix, BioWisdom Ltd., and Rosetta Biosoftware. Table of Contents Chapter 1. Executive Summary 1.1. Bioinformatics - Industry Summary and Critical Success Factors (CSFs) Chapter 2. Bioinformatics Industry Outlook 2.1. Market Segmentation 2.2. Market Size and Growth Prospects 2.3. Bioinformatics Market Dynamics 2.3.1. Market Driver Analysis 2.3.2. Market Restraint Analysis 2.4. Key Opportunities Prioritized 2.5. Industry Analysis - Porter's 2.6. Bioinformatics Market PESTEL Analysis, 2012 Chapter 3. Bioinformatics Product Outlook 3.1. Bioinformatics Platoforms 3.1.1. Bioinformatics Platforms Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.2. Sequence Analysis Platforms 3.1.2.1. Sequence Analysis Platforms Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.2.2. Structural and Functional Analysis Platforms 3.1.2.2.1. Structural and Functional Analysis Platforms Market Estimates and Forecasts, 2012 - 2020 3.1.2.3. Sequence Alignment Platforms
Follow Us:
3.1.2.3.1. Sequence Alignment Platforms Market Estimates and Forecasts, 2012 2020 (USD Million) 3.1.2.4. Sequence Manipulation Platforms 3.1.2.4.1. Sequence Manipulation Platforms Market Estimates and Forecasts, 2012 2020 (USD Million) 3.1.2.5. Others 3.1.2.5.1. Other Platforms Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.2. Biocontent Continue…………………. About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com
Follow Us: